Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers

This publication has 19 references indexed in Scilit:

• Induction of P-glycoprotein and cytochrome P450 3A by HIV protease inhibitors.
  2001
• Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers
  AIDS, 2001
• Inhibition of Human Cytochrome P450 Isoforms by Nonnucleoside Reverse Transcriptase Inhibitors
  The Journal of Clinical Pharmacology, 2001
• Delavirdine
  Clinical Pharmacokinetics, 2001
• Pharmacokinetic and Pharmacodynamic Study of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir after Multiple Oral Dosing
  Antimicrobial Agents and Chemotherapy, 2001
• Amprenavir
  Drugs, 2000
• Pharmacokinetic interaction of amprenavir in combination with efavirenz or delavirdine in HIV-infected children
  AIDS, 2000
• Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies
  AIDS, 1999
• Efficacy and Safety of Delavirdine Mesylate With Zidovudine and Didanosine Compared With Two-Drug Combinations of These Agents in Persons With HIV Disease With CD4 Counts of 100 to 500 cells/mm3 (ACTG 261)
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
• Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors
  Antimicrobial Agents and Chemotherapy, 1995